Previous 10 | Next 10 |
Where is the global economy headed? Are we at the start of a nasty and protracted recession, or will this just be a natural cyclical slowing, to be followed fairly soon thereafter by a cyclical reacceleration? If it's the former, then the stock market could be headed for a long slump, but i...
Up until recently, cannabis strains were divided into three distinct categories: indica, sativa, and hybrid. Indica use is reserved for pain relief, relaxation, and sleep; sativa is known for its uplifting, social, and creative properties; and hybrid strains fall somewhere in between depe...
Alexion Pharmaceuticals (NASDAQ: ALXN ) initiated with Outperform rating and $146 (45% upside) price target at William Blair. More news on: Alexion Pharmaceuticals, Inc., Change Healthcare Inc., Denali Therapeutics Inc., Healthcare stocks news, Stocks on the move, , Read more ...
PerkinElmer, Inc . (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it is giving notice of the redemption of all of its outstanding 5% Senior Unsecured Notes due in 2021 (the “2021 Notes”). In accordance with the terms of the ...
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $850 million aggregate principal amount of 3.300% Senior Notes due 2029 at an issue price of 99.670% of the principal amount. The issuance of the...
Bears were unrelenting yesterday, I stayed contrarian Every pundit and commentator I listen to was talking recession. Who could blame them with the heaviness to the market? Then the 10 am ISM number showed contraction, which should have surprised no one, and yet the market reacted badly. M...
PerkinElmer (NYSE: PKI ) Chairman & CEO Robert Friel will retire effective December 29 and will continue in an advisory role until March 1, 2020. More news on: PerkinElmer, Inc., Healthcare stocks news, Tech stocks news, Read more ...
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that after a career of more than 20 years at the Company, including the last 12 years as chief executive officer, Robert F. Friel, has decided to retire as chairman and CEO and memb...
PerkinElmer, Inc. (PKI) Q2 2019 Earnings Conference Call Jul 29, 2019 05:00 PM ET Company Participants Bryan Kipp - Vice President, Investor Relations Rob Friel - Chairman & Chief Executive Officer Prahlad Singh - President & Chief Operating Officer Jamey Mock - Senior ...
PerkinElmer (NYSE: PKI ) Q2 results ($M): Revenue: 722.5 (+27.2%). More news on: PerkinElmer, Inc., Healthcare stocks news, Tech stocks news, Earnings news and commentary, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...